120 related articles for article (PubMed ID: 32654200)
1. A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity.
Thibodeaux SR; McKenna DH; Szczepiorkowski ZM; Fontaine MJ; Kelley L; Reems JA; Young PP;
Transfusion; 2020 Aug; 60(8):1811-1820. PubMed ID: 32654200
[TBL] [Abstract][Full Text] [Related]
2. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.
Marijt WA; Veenhof WF; Goulmy E; Willemze R; van Rood JJ; Falkenburg JH
Blood; 1993 Dec; 82(12):3778-85. PubMed ID: 8260714
[TBL] [Abstract][Full Text] [Related]
3. Red Cell Depletion of Major ABO Incompatible Bone Marrow Hematopoietic Progenitor Cells HPC(M) with the Spectra Optia®.
Christensen A; Hsieh F; Boyer M; Couriel D; Reems JA
Ann Clin Lab Sci; 2020 Nov; 50(6):781-789. PubMed ID: 33334794
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
Watt SM; Austin E; Armitage S
Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
[TBL] [Abstract][Full Text] [Related]
5. Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.
Lane TA; Bashey A; Carrier E; Holman P; Castro J; Mullen M; Ward DM; Ada O; Ball ED
Cytotherapy; 2004; 6(4):318-27. PubMed ID: 16146884
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
[TBL] [Abstract][Full Text] [Related]
7. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
Clancy LE; Blyth E; Simms RM; Micklethwaite KP; Ma CK; Burgess JS; Antonenas V; Shaw PJ; Gottlieb DJ
Biol Blood Marrow Transplant; 2013 May; 19(5):725-34. PubMed ID: 23380344
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedure.
Cassens U; Ostkamp-Ostermann P; Garritsen H; Kelsch R; Ostermann H; Kienast J; Kiehl M; Buechner T; van de Loo J; Juergens H; Sibrowski W
Bone Marrow Transplant; 1997 Apr; 19(8):835-40. PubMed ID: 9134178
[TBL] [Abstract][Full Text] [Related]
11. Rationale for large scale bone marrow hemopoietic stem cell manipulation.
Menichella G; Pierelli L; Vittori M; Paoloni A; Foddai ML; Serafini R; Iacone A; Mango G
Haematologica; 1991 Mar; 76 Suppl 1():3-6. PubMed ID: 1677911
[TBL] [Abstract][Full Text] [Related]
12. Accommodating clinical trials and other externally manufactured cellular therapy products: challenges, lessons learned and creative solutions.
Jackson MR
Cytotherapy; 2022 Jan; 24(1):37-44. PubMed ID: 34305008
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
14. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
Dal MS; Tekgündüz E; Çakar MK; Kaya AH; Namdaroğu S; Batgi H; Bekdemir F; Uncu Ulu B; Yiğenoğlu TN; Kılınç A; İskender D; Uğur B; Koçubaba Ş; İskender G; Altuntaş F
Transfus Apher Sci; 2016 Aug; 55(1):125-8. PubMed ID: 27184293
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell processing and cryopreservation.
Rowley SD
J Clin Apher; 1992; 7(3):132-4. PubMed ID: 1363100
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
Körbling M; Przepiorka D; Huh YO; Engel H; van Besien K; Giralt S; Andersson B; Kleine HD; Seong D; Deisseroth AB
Blood; 1995 Mar; 85(6):1659-65. PubMed ID: 7888684
[TBL] [Abstract][Full Text] [Related]
17. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance and standards in hematopoietic progenitor processing.
Bennett ST; Johnson NL; Lasky LC
J Clin Apher; 1992; 7(3):138-44. PubMed ID: 1363102
[TBL] [Abstract][Full Text] [Related]
19. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
20. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.
Couban S; Simpson DR; Barnett MJ; Bredeson C; Hubesch L; Howson-Jan K; Shore TB; Walker IR; Browett P; Messner HA; Panzarella T; Lipton JH;
Blood; 2002 Sep; 100(5):1525-31. PubMed ID: 12176866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
